Cardiovascular Systems (NASDAQ: CSII) 20% LOWER; reported Q2 EPS of ($0.47), $0.03 better than the analyst estimate of ($0.50). Revenue ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Leerink Partners Cut Price Target on Cardiovascular Systems (CSII) Following Disappointing 2Q and 3Q Guidance January 22, 2016 9:22 AM Needham & Company Reiterates Buy on 8x8, Inc. (EGHT) Following Top and Bottom Line Beat January 22, 2016 9:09 AM Susquehanna Remains Sidelined on Maxim Integrated Products (MXIM) Following In-Line 2Q January 22, 2016 8:02 AM RBC Capital Remains Sidelined on Maxim Integrated Products (MXIM) Following In-Line Quarter Results January 22, 2016 7:28 AM Compass Point Cuts Price Target Following E*TRADE Financial's (ETFC) In-Line 4Q January 22, 2016 6:47 AM